Compound: piracetam
SMILES: O=C1N(CCC1)CC(=O)N
InChIKey: GMZVRMREEHBGGF-UHFFFAOYSA-N
Synonyms: piracetam, 7491-74-9, 2-(2-oxopyrrolidin-1-yl)acetamide, Nootropil, 2-Oxo-1-pyrrolidineacetamide, Nootropyl, Normabrain, Pyracetam, Pyramem, Pirazetam, Myocalm, 2-Pyrrolidinoneacetamide, Piracetamum, Nootrop, Cl-871, 1-Acetamido-2-pyrrolidinone, 2-Ketopyrrolidine-1-ylacetamide, DTXSID5044491, NSC-758191, ZH516LNZ10, DTXCID3024491, Piracetam RPh, Piracetam-RPh, Memo Puren, 2-Pyrrolidone-N-Acetamide, UCB6215, Nootrop 400, Nootrop 800, Nootrop 1200, RefChem:6146, N06BX03, 231-312-7, 1-Pyrrolidineacetamide, 2-oxo-, Euvifor, Gabacet, Genogris, Pirroxil, Nootron, 2-Oxo-pyrrolidine acetamide, 2-Pyrrolidoneacetamide, UCB 6215, UCB-6215, 2-Oxo-pyrrolidin-1-ylacetamide, MLS000069719, MFCD00079246, SMR000058196, Ciclofalina, NCGC00015821-02, CAS-7491-74-9, 2-(2-oxopyrrolidinyl)acetamide, Naofukang [Chinese], 2-(2-oxo-pyrrolidin-1-yl)acetamide, KT-801, Cerebroforte, Avigilen, Breinox, Naofukang, Norzetam, Axonyl, Geram, Piracetamum [INN-Latin], SR-01000076071, EINECS 231-312-7, BRN 1526393, UNII-ZH516LNZ10, Encetrop, Piracetam [USAN:INN:BAN], 2-(2-Oxopyrrolidino)acetamide, Piracetam CRS, HSDB 7529, Prestwick_870, 2-(2-Oxo-1-pyrrolidinyl)acetamide, Myocalm (TN), Piracetam (Standard), Piracetam, EP6.0, Spectrum_001421, PIRACETAM [INN], PIRACETAM [JAN], PIRACETAM [MI], PIRACETAM [HSDB], PIRACETAM [USAN], Opera_ID_1766, Prestwick0_000537, Prestwick1_000537, Prestwick2_000537, Prestwick3_000537, Spectrum2_001074, Spectrum3_001523, Spectrum4_000742, Spectrum5_001037, Lopac-P-5295, PIRACETAM [MART.], (2-Oxopyrrolidino)acetamide, cid_4843, PIRACETAM [WHO-DD], Lopac0_000949, Oprea1_512927, SCHEMBL20172, BSPBio_000553, BSPBio_002906, KBioGR_001064, KBioSS_001901, 5-21-06-00360 (Beilstein Handbook Reference), Piracetam (JAN/USAN/INN), 2-Oxo-1-pyrrolidinylacetamide, CHEMBL36715, DivK1c_000259, SPECTRUM1502195, Piracetam - Bio-X trade mark, SPBio_001088, SPBio_002474, 2-(2-ketopyrrolidino)acetamide, BPBio1_000609, GTPL4288, orb1310628, SCHEMBL7769433, PIRACETAM [EP MONOGRAPH], BDBM62877, CHEBI:32010, Cl-781, HMS500M21, HY-B0585R, KBio1_000259, KBio2_001901, KBio2_004469, KBio2_007037, KBio3_002406, Oxiracetam Impurity A; Piracetam, Oxiracetam impurity 7(Piracetam), NINDS_000259, HMS1569L15, HMS1921L12, HMS2092D18, HMS2096L15, HMS2230B24, HMS3262N20, HMS3371G01, HMS3657A05, HMS3713L15, HMS3885I07, HMS5081I12, Pharmakon1600-01502195, ALBB-038663, EDC79964, HY-B0585, MSK10625, Tox21_110229, Tox21_301990, Tox21_500949, BBL028161, CCG-39282, EBC-04296, HB0507, NSC758191, s3070, SBB086233, STK535612, AKOS001038683, Tox21_110229_1, 2-(2-Oxo-1-pyrrolidinyl)acetamide #, DB09210, FP27078, LP00949, NSC 758191, SDCCGSBI-0050923.P004, IDI1_000259, NCGC00015821-01, NCGC00015821-03, NCGC00015821-04, NCGC00015821-05, NCGC00015821-06, NCGC00015821-07, NCGC00015821-08, NCGC00015821-10, NCGC00015821-21, NCGC00094253-01, NCGC00094253-02, NCGC00094253-03, NCGC00094253-04, NCGC00255727-01, NCGC00261634-01, AC-33158, AS-13920, BP166248, SY066794, SBI-0050923.P003, DB-019407, AB00052287, EU-0100949, NS00000504, P2880, ST50182453, SW196995-3, 2-(2-oxidanylidenepyrrolidin-1-yl)ethanamide, EN300-17044, Piracetam, VETRANAL(TM), analytical standard, D01914, P 5295, AB00052287_12, AE-641/30117005, F787594, Q410069, SR-01000076071-1, SR-01000076071-4, SR-01000076071-6, BRD-K19456237-001-22-7, BRD-K19456237-001-26-8, BRD-K19456237-001-27-6, Z56865289, F1918-0022, Piracetam, European Pharmacopoeia (EP) Reference Standard
Theoretical properties:
molecular_formula: C6H10N2O2
molecular_weight: 142.16 g/mol
exact_mass: 142.074227566 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 2
heavy_atom_count: 10
topological_polar_surface_area: 63.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
physical_state: Crystals from isopropanol
color: Crystals from isopropanol
boiling_point: Decomposes
Descriptions:
pubchem: Piracetam is an organonitrogen compound and an organooxygen compound. It is functionally related to an alpha-amino acid.
chembl: PIRACETAM is a small molecule listed in the ChEMBL database and has reached clinical trial phase 3.0.
wikipedia: Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. Piracetam is sold as a medication in many European countries. Piracetam in the United States is not approved for general use.
Piracetam is in the racetams group, with chemical name 2-oxo-1-pyrrolidine acetamide. It is a cyclic derivative of the neurotransmitter GABA and shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid. Related drugs include the anticonvulsants levetiracetam and brivaracetam, and the putative nootropics aniracetam and phenylpiracetam.